EGFR and cancer: A similar result was also reported in a recent study focused on an Asian population, with that study reporting that NSCLC patients with mutated EGFR had a higher cumulative incidence of subsequent BM, in addition to reporting that further in vitro exploration showed that mutated EGFR tumors trigger mesenchymal-like phenotype transformation and induce cancer cell dissemination [11].